SBI Securities’s Quoin Pharmaceuticals QNRX Stock Holding History

SBI Securities’s Portfolio QNRX Stock Details QNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$584	Sell	128 -227	-64%	-$1.22K	﹤0.01%	3063
2026 Q2	$1.72K	Buy	355 +353	+17,650%	+$1.9K	﹤0.01%	2604
2026 Q1	$13	Sell	2 -245	-99%	-$2.22K	﹤0.01%	3820
2025 Q4	$3.56K	Buy	247 +245	+12,250%	+$3.34K	﹤0.01%	2163
2025 Q3	$14	Hold	2	–	–	﹤0.01%	3982
2025 Q2	$18	Sell	2 -1	-33%	-$8	﹤0.01%	3933
2025 Q1	$24	Buy	3 +2	+200%	+$26	﹤0.01%	3819
2024 Q4	$16	Buy	+1	New	+$23	﹤0.01%	3875

Other funds holding QNRX

Stonepine Capital Management Bend, Oregon $159M AUM 62.27% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return

NCNMGF

Nano-Cap New Millennium Growth Fund Staten Island, New York $140M AUM 44.76% 1-Year Est. Return

Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $134B AUM 35.21% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Arax Advisory Partners Denver, Colorado $17.7B AUM 20.22% 1-Year Est. Return

SBI Securities's QNRX Position: Q3 2026 in Review

SBI Securities reduced its Quoin Pharmaceuticals (QNRX) stake by 64% in Q3 2026, selling an estimated $1.22K and leaving 128 shares worth $584. The position accounts for ﹤0.01% of the portfolio, ranked #3063.

SBI Securities first reported a position in QNRX in Q4 2024 and has held it in 8 quarters since. The position peaked at $3.56K in Q4 2025. 13 funds tracked by Wall St. Rank hold QNRX as of Q3 2026.

SBI Securities held 128 shares of Quoin Pharmaceuticals worth $584 as of Q3 2026.
SBI Securities sold 227 Quoin Pharmaceuticals shares in Q3 2026, an estimated $1.22K.
Quoin Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3063 holding.
SBI Securities first reported a position in Quoin Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
SBI Securities's Quoin Pharmaceuticals position peaked at $3.56K in Q4 2025.
13 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.